Court Rules For Pfizer In Accupril Patent Suit

Law360, New York (July 1, 2004, 12:00 AM EDT) -- A U.S. district court judge has ruled that Pfizer’s patents for Accupril are valid, dealing Israeli drug maker Teva a blow in its efforts to market a generic version of the $600 million blood pressure medicine.

In a June 29 decision, Judge Dickinson R. Debevoise of the U.S. District Court for the District of New Jersey held that Warner-Lambert's patent on a stable formulation of quinapril, the generic name of the drug, was valid, infringed and enforceable against Teva, Pfizer said.

The decision affirmed the court's...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.